Share

Guangzheng Eye Hospital Group Co.,Ltd. Stocks

CN¥ 4.41Last Updated 30.04.2026

Issuer Rating

3/7
Performance

Poor

Risk

Limited

Recommendation

Sell

Market Cap

CN¥ 320.28M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 4.41
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Guangzheng Eye Hospital Group Co., Ltd. provides ophthalmic medical services in China. It invests in and manages ophthalmic hospitals. The company opeates13 eye hospitals and 1 optometry clinic in Shanghai, Chengdu, Chongqing, Zhengzhou, Nanchang, Hohhot, Jinan, Qingdao, Wuxi, Yiwu, etc. In addition, it is involved in the design, manufacture, installation, and after-sales service of light steel, heavy steel, multi-high-rise stee, and space and long-span steel structures, as well as construction of steel bridges and systems. Further, the company is engaged in natural gas transportation and operation of gas filling stations. Guangzheng Eye Hospital Group Co., Ltd. was founded in 2001 and is headquartered in Urumqi, the People's Republic of China.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is overpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks